Sexual dysfunction associated with antidepressant therapy (Q36993680)

17 August 2017

1 reference

title

Sexual dysfunction associated with antidepressant therapy (English)

1 reference

17 August 2017

1 reference

Robert Taylor Segraves

series ordinal

1

1 reference

17 August 2017

1 November 2007

1 reference

Urologic Clinics of North America

17 August 2017

1 reference

17 August 2017

34

1 reference

17 August 2017

4

1 reference

17 August 2017

575-9, vii

1 reference

Female sexual disorders: psychiatric aspects

17 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.003

Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.003

Effects of SSRIs on sexual function: a critical review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.003

Anorgasmia from clomipramine in obsessive-compulsive disorder. A controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.003

SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.003

Persistent sexual side effects after SSRI discontinuation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.003

Evaluation of sexual functioning in depressed outpatients: a double-blind comparison of sustained-release bupropion and sertraline treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.003

A placebo-controlled comparison of the effects on sexual functioning of bupropion sustained release and fluoxetine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.003

Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.003

Sexual functioning assessed in 4 double-blind placebo- and paroxetine-controlled trials of duloxetine for major depressive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.003

Fluoxetine-induced sexual dysfunction: a dose-dependent effect?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.003

Intermittent amantadine for fluoxetine-induced anorgasmia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.003

Psychostimulants apparently reverse sexual dysfunction secondary to selective serotonin re-uptake inhibitors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.003

Ginkgo biloba for antidepressant-induced sexual dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.003

Resolution of fluoxetine-induced sexual dysfunction with the 5-HT3 antagonist granisetron.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.003

Treatment of drug-induced anorgasmia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.003

Augmentation With Open-Label Atomoxetine for Partial or Nonresponse to Antidepressants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.003

Strategies for managing antidepressant-induced sexual dysfunction: systematic review of randomised controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.003

Treatment of antidepressant-associated sexual dysfunction with sildenafil: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.003

Tadalafil for treatment of erectile dysfunction in men on antidepressants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.003

Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.003

Bupropion sustained release for the treatment of hypoactive sexual desire disorder in premenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.003

Citalopram-associated clitoral priapism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.003

Unusual side effects of clomipramine associated with yawning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.003

A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.003

7 January 2021

inferred from DOI database lookup

Citalopram-associated clitoral priapism: a case series

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.003

7 January 2021

inferred from DOI database lookup

Neurochemical aspects of the sexual response cycle

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.003

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1016/J.UCL.2007.08.003

1 reference

release_qbo7e6weere6hfe3spriqbhvwu

17 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qbo7e6weere6hfe3spriqbhvwu

24 November 2022

mapped directly with Wikidata item

PubMed ID

17983897

1 reference

PubMed ID

17983897